These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease? Gitler AD Neurosignals; 2008; 16(1):52-62. PubMed ID: 18097160 [TBL] [Abstract][Full Text] [Related]
6. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders. Ocampo A; Barrientos A Biotechniques; 2008 Oct; 45(4):vii-xiv. PubMed ID: 18855765 [TBL] [Abstract][Full Text] [Related]
7. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Outeiro TF; Giorgini F Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706 [TBL] [Abstract][Full Text] [Related]
9. Split-EGFP screens for the detection and localisation of protein-protein interactions in living yeast cells. Barnard E; Timson DJ Methods Mol Biol; 2010; 638():303-17. PubMed ID: 20238279 [TBL] [Abstract][Full Text] [Related]
10. The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration. Chen Q; Ding Q; Keller JN Biogerontology; 2005; 6(1):1-13. PubMed ID: 15834659 [TBL] [Abstract][Full Text] [Related]
11. Human XPA and XRCC1 DNA repair proteins expressed in yeast, Saccharomyces cerevisiae. Pushnova EA; Ostanin K; Thelen MP Mol Genet Metab; 2001 Nov; 74(3):380-4. PubMed ID: 11708869 [TBL] [Abstract][Full Text] [Related]
12. Demented flies? Using Drosophila to model human neurodegenerative diseases. Michno K; van de Hoef D; Wu H; Boulianne GL Clin Genet; 2005 Jun; 67(6):468-75. PubMed ID: 15857410 [TBL] [Abstract][Full Text] [Related]
13. Transformation of yeast by infectious prion particles. King CY; Wang HL; Chang HY Methods; 2006 May; 39(1):68-71. PubMed ID: 16759879 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetics approaches in yeast to study amyloid diseases. Outeiro TF; Muchowski PJ J Mol Neurosci; 2004; 23(1-2):49-60. PubMed ID: 15126692 [TBL] [Abstract][Full Text] [Related]
15. Yeast as a model for studying human neurodegenerative disorders. Miller-Fleming L; Giorgini F; Outeiro TF Biotechnol J; 2008 Mar; 3(3):325-38. PubMed ID: 18228539 [TBL] [Abstract][Full Text] [Related]
16. An approach to studying the localization and dynamics of eukaryotic translation factors in live yeast cells. Campbell SG; Ashe MP Methods Enzymol; 2007; 431():33-45. PubMed ID: 17923229 [TBL] [Abstract][Full Text] [Related]
17. New insights into cancer-related proteins provided by the yeast model. Pereira C; Coutinho I; Soares J; Bessa C; Leão M; Saraiva L FEBS J; 2012 Mar; 279(5):697-712. PubMed ID: 22239976 [TBL] [Abstract][Full Text] [Related]
18. A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. D'Angelo F; Vignaud H; Di Martino J; Salin B; Devin A; Cullin C; Marchal C Dis Model Mech; 2013 Jan; 6(1):206-16. PubMed ID: 22888099 [TBL] [Abstract][Full Text] [Related]
19. Emerging roles of J proteins in neurodegenerative disorders. Gibbs SJ; Braun JE Neurobiol Dis; 2008 Nov; 32(2):196-9. PubMed ID: 18760363 [TBL] [Abstract][Full Text] [Related]
20. Symmetry breaking: scaffold plays matchmaker for polarity signaling proteins. Atkins BD; Yoshida S; Pellman D Curr Biol; 2008 Dec; 18(24):R1130-2. PubMed ID: 19108767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]